Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Atorvastatin/Glimepiride FDC vs Loose Combination in T2D
NCT01495013Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 2011
- Primary completion
- Apr 2013
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 3 trial of glimepiride, atorvastatin in type 2 diabetes mellitus (T2DM), dyslipidemia, sponsored by GSK. Started Dec 2011; status: completed.
02
Drugs
glimepirideatorvastatin
03
Conditions
type 2 diabetes mellitus (T2DM)dyslipidemia
Beyond the preview
Go deeper on NCT01495013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01495013.